Groups hit hardest by the COVID-19 pandemic have historically been underrepresented in clinical trials for disease treatment.
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
Despite their personal uncertainty, when a doctor approached the ailing couple at their bedsides to ask if they would consent to join a study of an experimental drug to help experts learn to treat COVID-19, each agreed.
Importation of prescription drugs to lower costs is being proposed by the Trump Administration using demonstration projects and other pathways. Safety concerns and monitoring have yet to be addressed, but it could be human experimentation without informed
Public Awareness Campaign on Sex Differences in Heart Disease and Improving Recruitment and Retention of Women in Device Trials
Women experience different signs and symptoms of heart disease, which can lead to ineffective, delayed or missed treatment opportunities.
Medical marijuana is generating greater attention as more states legalize its use. However, there are many different active chemical compounds in the different strains of the cannabis plant.
Every drug that makes it to the pharmacy shelf must leap over numerous hurdles, starting with experimentation in the lab, followed by clinical trials in humans and culminating with the scrutiny of the U.S. Food and Drug Administration (FDA), which must review and approve all proposed new medications for safety and effectiveness before they can be sold to consumers.